Prioritizing Ligandable RNA Targets with AI-Enabled Structure Prediction & Functional Validation

• Predicting RNA structural features that may support selective small-molecule binding
• Distinguishing structurally interesting RNAs from targets with functional therapeutic relevance
• Using model-guided experimental validation to select targets before investing in screening

Speakers:

Raphael Townshend

Founder & Chief Executive Officer

Atomic AI